Dow Up 1.31% Nasdaq Up 2.40%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
6.85 Down 0.05(0.72%) 4:00PM EDT
Prev Close:6.90
Open:6.93
Bid:6.00 x 200
Ask:7.30 x 1000
1y Target Est:11.33
Beta:2.16
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:6.64 - 6.94
52wk Range:5.22 - 13.64
Volume:379,060
Avg Vol (3m):1,096,680
Market Cap:297.13M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACRX

Comparison

Symbol% ChgMkt Cap
ACRXDown 0.72%297.13M
BAXUp 1.05%37.19B
CFNUp 0.35%11.50B
HSPUp 2.03%8.59B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.07
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback